MedTrace Logo

Impact of Microfinance and Participatory Gender Training for Women in Reducing Intimate Partner Violence

NCT02592252 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2640

Last updated 2018-03-26

No results posted yet for this study

Summary

Violence against women and girls is increasingly recognized as a major global public health and development concern. However, evidence on what forms of intervention should be prioritised is severely lacking. A cluster randomized controlled trial (The Intervention with Microfinance for AIDS \& Gender Equity - IMAGE Project) in rural South Africa combined a group-based microfinance intervention with a participatory gender and HIV training curriculum for loan participants and showed that, over a two-year period, levels of physical and/or sexual partner violence experienced by participants in the past year were reduced by 55%.

The overall goal of the current study is to design and implement a cluster randomized controlled trial to assess the impact on intimate partner violence of: 1) combining participatory gender training with microfinance for women in existing microfinance loan groups, and 2) a participatory gender training programme for women (not receiving microfinance) and their male partners.

Conditions

  • Maltreatment by Spouse or Partner

Interventions

BEHAVIORAL

Participatory gender training

10 sessions of participatory gender training

OTHER

Microfinance

Microfinance loan

Sponsors & Collaborators

  • Mwanza Intervention Trials Unit

    collaborator OTHER

  • National Institute for Medical Research, Tanzania

    collaborator OTHER_GOV

  • Bangladesh Rural Advancement Committee

    collaborator OTHER

  • EngenderHealth

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-07-31
Completion
2019-12-31

Countries

  • Tanzania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02592252 on ClinicalTrials.gov